https://www.selleckchem.com/pr....oducts/17-AAG(Geldan
1% and 47.1% (p0.05) of migrants and natives who eradicated HCV, respectively. Compared to natives, HCV-infected migrants in care have different demographics, HCV genotypes, viral coinfections and comorbidities and similar disease severity, SVR and cofactors for disease progression after HCV eradication. A periodic clinical assessment after HCV eradication in Italians and migrants with cofactors for disease progression is warranted. Compared to natives, HCV-infected migrants in care have different demographics, HCV geno
Like
Comment
Share
